X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (829) 829
Publication (238) 238
Newspaper Article (29) 29
Book Chapter (3) 3
Book Review (3) 3
Patent (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (482) 482
index medicus (380) 380
hiv (289) 289
infectious diseases (270) 270
male (252) 252
hiv infections - drug therapy (251) 251
immunology (250) 250
female (242) 242
adult (225) 225
hiv infections - immunology (198) 198
middle aged (190) 190
antiretroviral therapy (167) 167
hiv infections - virology (167) 167
human immunodeficiency virus--hiv (165) 165
virology (164) 164
hiv infection (162) 162
aids (150) 150
viral load (141) 141
article (127) 127
research (122) 122
microbiology (118) 118
cd4 lymphocyte count (113) 113
drug therapy (109) 109
anti-hiv agents - therapeutic use (99) 99
antiretroviral drugs (94) 94
health aspects (91) 91
antiretroviral therapy, highly active (87) 87
infections (85) 85
care and treatment (84) 84
antiviral agents (83) 83
hiv-1 - genetics (83) 83
acquired immune deficiency syndrome--aids (82) 82
human immunodeficiency virus (82) 82
t cells (82) 82
abridged index medicus (81) 81
hiv-1 - drug effects (80) 80
infection (79) 79
lymphocytes (79) 79
human-immunodeficiency-virus (75) 75
immune activation (75) 75
rna, viral - blood (74) 74
viruses (73) 73
disease progression (72) 72
cohort studies (71) 71
cd4-positive t-lymphocytes - immunology (70) 70
aids/hiv (69) 69
mortality (69) 69
medicine (67) 67
risk factors (67) 67
rna (67) 67
research article (66) 66
hiv-1 - immunology (65) 65
highly active antiretroviral therapy (64) 64
virus diseases (63) 63
cd8-positive t-lymphocytes - immunology (62) 62
hiv infections - complications (60) 60
hiv-1 - physiology (60) 60
inflammation (58) 58
treatment outcome (57) 57
replication (56) 56
multidisciplinary sciences (55) 55
therapy (55) 55
acquired immune deficiency syndrome (53) 53
disease (49) 49
lymphocytes t (49) 49
immunodeficiency-virus type-1 (48) 48
activation (47) 47
analysis (47) 47
hiv-1 (47) 47
active antiretroviral therapy (46) 46
medicine, general & internal (46) 46
hiv/aids (45) 45
medical research (43) 43
antiretrovirals (42) 42
science (42) 42
biology (41) 41
hiv patients (41) 41
physiological aspects (41) 41
risk (40) 40
t lymphocytes (40) 40
anti-retroviral agents - therapeutic use (38) 38
cd4 antigen (38) 38
cd4-positive t-lymphocytes - virology (38) 38
drug resistance (38) 38
mutation (38) 38
viremia (38) 38
antiretroviral agents (37) 37
dosage and administration (36) 36
hiv infections - blood (36) 36
hiv infections - genetics (36) 36
in-vivo (36) 36
cd4 t-cells (35) 35
dna (34) 34
hiv 1 (34) 34
hiv infections (34) 34
lymphocyte activation (34) 34
epidemiology (33) 33
genetic aspects (33) 33
immune response (33) 33
individuals (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Pathogens, ISSN 1553-7366, 02/2013, Volume 9, Issue 2, p. e1003174
HIV-1 reservoirs preclude virus eradication in patients receiving highly active antiretroviral therapy (HAART). The best characterized reservoir is a small,... 
LOW-LEVEL VIREMIA | PLASMA VIREMIA | CD4(+) T-CELLS | MICROBIOLOGY | PERIPHERAL-BLOOD | BLOOD MONONUCLEAR-CELLS | LATENT HIV-1 | INFECTED INDIVIDUALS | VIROLOGY | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | PARASITOLOGY | Proviruses - isolation & purification | Disease Reservoirs - virology | Humans | Middle Aged | DNA, Viral - analysis | Male | Leukocytes, Mononuclear - virology | RNA, Viral - genetics | Proviruses - genetics | Virus Integration - drug effects | Polymerase Chain Reaction | Adult | Female | DNA, Viral - drug effects | Leukocytes, Mononuclear - drug effects | HIV Infections - genetics | HIV Infections - virology | RNA, Viral - analysis | HIV - isolation & purification | Proviruses - growth & development | HIV - growth & development | Antiretroviral Therapy, Highly Active | HIV - genetics | HIV Infections - drug therapy | Aged | DNA, Viral - genetics | RNA, Viral - drug effects | Viral Load - drug effects | Longitudinal Studies | CD4-Positive T-Lymphocytes - drug effects | Physiological aspects | HIV patients | Virulence (Microbiology) | Research | T cells | Health aspects | Plasma | Clinical trials | Statistical methods | Infections | Genomes | Grants | Experiments | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Normal distribution | Human immunodeficiency virus--HIV | Drug therapy | Deoxyribonucleic acid--DNA | AIDS | HIV | Acquired immune deficiency syndrome | Deoxyribonucleic acid | DNA | Human immunodeficiency virus
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 02/2011, Volume 62, Issue 1, pp. 141 - 155
Although antiretroviral therapy for HIV infection prevents AIDS-related complications and prolongs life, it does not fully restore health. Long-term treated... 
CD28 | frailty | CD38 | CMV | telomere | MEDICINE, RESEARCH & EXPERIMENTAL | LIFE-SPAN | MYOCARDIAL-INFARCTION | ANTIRETROVIRAL THERAPY | CYTOMEGALOVIRUS-INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | REPLICATIVE SENESCENCE | REVERSE-TRANSCRIPTASE INHIBITORS | T-CELL RESPONSES | CALORIC RESTRICTION | IMMUNE ACTIVATION | Immune System - virology | Humans | Mitochondrial Diseases - immunology | T-Lymphocytes - virology | HIV Infections - immunology | Neoplasms - virology | Aging - immunology | Cardiovascular Diseases - virology | Aging - genetics | Anti-HIV Agents - therapeutic use | Metabolic Syndrome - immunology | Intra-Abdominal Fat - immunology | Intra-Abdominal Fat - virology | Liver Diseases - immunology | Liver Diseases - virology | Bone Diseases - virology | Mitochondrial Diseases - virology | Inflammation - virology | Treatment Outcome | Inflammation - immunology | Bone Diseases - immunology | Antiretroviral Therapy, Highly Active | Kidney Diseases - immunology | Cardiovascular Diseases - immunology | Neoplasms - immunology | HIV Infections - complications | Metabolic Syndrome - virology | HIV Infections - drug therapy | Kidney Diseases - virology | Nervous System Diseases - virology | T-Lymphocytes - immunology | Nervous System Diseases - immunology | Anti-HIV Agents - immunology | Prevention | Aging | Physiological aspects | Telomeres | Care and treatment | HIV infection
Journal Article
PLoS Pathogens, ISSN 1553-7366, 05/2013, Volume 9, Issue 5, p. e1003347
Journal Article
PLOS MEDICINE, ISSN 1549-1676, 11/2017, Volume 14, Issue 11, p. e1002417
Background It is unknown if extremely early initiation of antiretroviral therapy (ART) may lead to long-term ART-free HIV remission or cure. As a result, we... 
MEDICINE, GENERAL & INTERNAL | HIGH SERUM-LEVEL | SOLUBLE CD30 | IMMUNODEFICIENCY-VIRUS-INFECTION | STRUCTURED TREATMENT INTERRUPTION | IMMUNE ACTIVATION | POSITIVE PATIENTS | CD4(+) T-CELLS | PREEXPOSURE PROPHYLAXIS | CEREBROSPINAL-FLUID | UNDETECTABLE VIRAL LOADS | HIV-1 | Recurrence | Anti-Retroviral Agents - therapeutic use | Prospective Studies | HIV Infections - virology | Humans | Middle Aged | Biomarkers - analysis | Male | Treatment Outcome | Secondary Prevention | HIV Infections - immunology | Phenotype | Flow Cytometry | Adult | HIV Infections - drug therapy | Antiviral agents | Evaluation | Health behavior | Development and progression | Dosage and administration | Drug therapy | HIV infection | Cell culture | Therapy | Funding | Leukocytes (mononuclear) | Cerebrospinal fluid | Assaying | Blood | Gene sequencing | Tenofovir | Acquired immune deficiency syndrome--AIDS | Animal tissues | Human immunodeficiency virus--HIV | Bone marrow | Public health | Deoxyribonucleic acid--DNA | Emtricitabine | Medical research | Tumor markers | Cytokines | Low level | Ileum | Antiretroviral therapy | Infectious diseases | Rectum | Software | Mice | Lymph | Viremia | Prophylaxis | Lymphocytes T | Infections | Genomes | Lymph nodes | Immunology | CD30 antigen | Mouse devices | Lymphocytes | Antiretroviral agents | Peripheral blood mononuclear cells | Remission | Tumor necrosis factor-TNF | Mathematical models | Supervision | Latent infection | Ribonucleic acid--RNA | CD4 antigen | Medicine | Bone | Cancer | RNA | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | Deoxyribonucleic acid | Ribonucleic acid | HIV | DNA
Journal Article
Immunity, ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 633 - 645
Combination antiretroviral therapy for HIV infection improves immune function and eliminates the risk of AIDS-related complications but does not restore full... 
MUCOSAL IMMUNE RECONSTITUTION | RECEIVING ANTIRETROVIRAL THERAPY | MONOCYTE ACTIVATION | INTESTINAL EPITHELIAL BARRIER | CD4(+) T-CELLS | CARDIOVASCULAR-DISEASE EVENTS | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | MICROBIAL TRANSLOCATION | D-DIMER | Intestinal Mucosa - physiopathology | Age Factors | Humans | Protein Biosynthesis - immunology | HIV - immunology | Monocytes - immunology | Liver - physiopathology | Thrombophilia - etiology | Thrombophilia - immunology | HIV Infections - immunology | Liver - immunology | Intestinal Mucosa - immunology | Monocytes - pathology | Anti-Inflammatory Agents - therapeutic use | Anti-HIV Agents - therapeutic use | Thrombophilia - drug therapy | Thrombophilia - physiopathology | Inflammation - immunology | Immunity, Innate | Inflammation - etiology | Models, Immunological | Multiple Organ Failure - etiology | HIV Infections - complications | Multiple Organ Failure - immunology | HIV Infections - drug therapy | HIV Infections - physiopathology | Multiple Organ Failure - physiopathology | Chronic Disease | Inflammation - physiopathology | Highly active antiretroviral therapy | AIDS vaccines | Analysis | Protein biosynthesis | Inflammation | HIV (Viruses) | Health aspects | HIV infection | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Drug therapy | Human immunodeficiency virus--HIV | Mortality
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e110731
Journal Article